Navigation Links
Vegan diet promotes atheroprotective antibodies in patients with rheumatoid arthritis
Date:3/18/2008

A gluten-free vegan diet may improve the health of patients with rheumatoid arthritis, according to new research from the Swedish medical universit Karolinska Institutet. The diet has a beneficial effect on several risk factors for cardiovascular disease.

Rheumatoid arthritis is associated with an increased risk of atherosclerosis (hardening of the arteries) and cardiovascular diseases. The underlying causes are unknown, but researchers suspect that the disturbed balance of blood fats seen in patients with rheumatoid arthritis may be part of the explanation.

A research team at Karolinska Institutet has shown in a new study that a gluten-free vegan diet has a beneficial effect on cardiovascular risk factors in people with rheumatoid arthritis. The effect was seen when a group of patients who kept to a gluten-free vegan diet for a year were compared with a control group which had followed ordinary dietary advice.

Vegan food had a positive effect on symptoms of the disease, which were more pronounced in the control group. Blood levels of oxidised LDL-cholesterol, a risk factor for atherosclerosis, were also lower in the group which kept to the vegan diet. The vegan group also had higher levels of anti-PC, a type of antibody that the researchers believe has a protective effect against atherosclerosis.

Our findings suggest a new mechanism by which the level of natural protective antibodies can be increased. They also show that diet can have effects on the immune system with implications for the incidence of disease, says Professor Johan Frostegrd, who led the study.

The study was initiated by Professor Ingild Hafstrm and was carried out within the framework of CVDIMMUNE, an EU consortium of ten European partners led by Johan Frostegrd. The consortium is studying the significance of anti-PC in the hope of developing a vaccine against atherosclerosis.


'/>"/>

Contact: Katarina Sternudd
katarina.sternudd@ki.se
46-852-483-895
Karolinska Institutet
Source:Eurekalert

Page: 1

Related medicine news :

1. Anthem Blue Cross and Blue Shield Acts to Support Las Vegans Impacted by Endoscopy Center Practices
2. New Brain Fitness Training Promotes Health and Independence of Long Term Care Insurance Policyholders
3. Isolagen, Inc. Promotes Todd Greenspan to Chief Financial Officer (CFO)
4. Deloittes Connected Care Model Promotes Technologically Enabled In-Home Health Care, Projects Future Health Care Savings in the Billions
5. Paradigm shift: Switch for programmed cell death promotes spread of glioblastoma
6. Precyse Solutions Promotes Ken Lacy to Senior Vice President & CIO to Drive Advancement of PrecyseNet(TM), Precyses Advanced Technology Solution
7. Therap Services Promotes Mozammel Haque to Project Manager
8. Blue Cross Promotes Two Leaders in Public Affairs
9. Schering-Plough Promotes Ian Mcinnes to President of Global Supply Chain
10. Davis Vision, United Concordia Free Clinic Promotes Childrens Eye and Dental Health
11. Transitions Optical Promotes Healthy Sight Through a Nationwide Integrated Advertising Campaign and the Launch of an Enhanced Consumer Web Site
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...Finding may lead to new therapies for preterm labo...- Researchers say they,ve found the switch that ac... childbirth, a finding that may lead to therapies ... normally binds the protein IP on the surface of t... inactive during pregnancy. , But researchers ...
(Date:11/21/2008)...Special meeting of shareholders to be held on Janu...e-FirstCall/ - Med-Emerg International Inc. ("MedE...iders of health services, announced today that it ...erior Court of Justice concerning its previously a...ursuant to which AIM Health Group Inc. ("AIM") wil...
(Date:11/21/2008)... HOUSTON(Nov. 21, 2008)The University of Texas Hea...ogram, Training Excellence in Aging Studies (TEXAS...hrough a prestigious $2 million award from the Don...tching funds., "This will allow us to teach geria... junior medical student to practicing physicians. ...
(Date:11/21/2008)...LOVELAND, Colo., Nov. 21 ...ced it will present at the New York Society of,Se... Pharma Conference on,December 2, 2008 at 1177 Av...The presentation is scheduled to begin at 9:35 a.m... be available via live webcast and for two weeks,...
Breaking Medicine News(10 mins):Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 2Health News:Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc. 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 4
...heir counterparts in the Health department of the ...g// a fast-food joint swarming with rats to contin...sible for the “shoddy audit” resigned Monday. The...d on videotape, created a national stir and prompt...
... with diabetes has another new risk- it heightens ...ou think and learn//, and may in fact set you on t... in the April issue of Archives of Neurology, one ... "Among cardiovascular risk factors, type 2 diabe...
...ed out to mark Mental Health Action Week, in Scotl...friends// who have experienced mental distress at ...at almost 90 percent of those suffering from menta...ing it to others, out of shame for appearing weak ...
... the Framingham Heart Study, dietary fat intake is...or 13 percent// of the study population with a spe...ne (APOA5), higher dietary fat was not related to ...gues analyzed several common gene variants known a...
Other Medicine News:Health News:Officials Indicted for Allowing a Fast Food Joint Teeming With Rats in New York to Function 2Health News:Diabetes May Bring You A Step Closer To Alzheimer’s Diseas 2Health News:Study Finds Dietary Fat Interacts With Genes 2Health News:Study Finds Dietary Fat Interacts With Genes 3
(Date:11/20/2008)...wswire/ -- The Scandinavian-based drug,developmen... studies on its,lead antimicrobial candidate LTX-...udies showed that the novel lytic peptidomimetic h...ntly better towards killing Staphylococcus,aureus...ndard drugs. In,addition to this it has proven ef...
(Date:11/19/2008)...tistical significance , , ISELIN, N.J., Nov...n (Nasdaq: PARS ) today announced results from i...sion (NE) drug delivery technology formulated with...i-center, randomized, double-blinded, placebo-cont...the Company,s 3% Diclofenac Diethanolamine NanoEmu...
(Date:11/19/2008)... Isogen, a contract development and,manufacturing... the first,phase launch of its contract facility ...ddress the process, facility and capacity problems...iched, low-volume clinical and,early-stage commer...anies can invest over $100 million and four years ...
(Date:11/18/2008)...rn more, make a donation or send a Christmas Seals...-USNewswire/ -- Millions will receive Christmas Se...an Lung Association. These decorative holiday stam...ing back to 1907 when the Lung Association led eff...mericans alive today have no vivid memories of how...
Breaking Medicine Technology:Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Isogen Launches Major New Facility to Address Global Biopharma Demand 2American Lung Association Celebrates 101st Annual Christmas Seals Campaign 2Desert Radiologists Sets Safe Practice Standards 17314 1Desert Radiologists Sets Safe Practice Standards 17314 2The Penis Diet 3A A Healthy Solution for Men Challenged by Erectile Dysfunction 17312 1The Penis Diet 3A A Healthy Solution for Men Challenged by Erectile Dysfunction 17312 2Chocolate bar shown to lower cholesterol 2976 1Chocolate bar shown to lower cholesterol 2976 2Health Plan One Closes 246 5 Million Series A Financing 17309 1Health Plan One Closes 246 5 Million Series A Financing 17309 2Health Plan One Closes 246 5 Million Series A Financing 17309 3
...linical Results Demonstrate Potential of ONCONASE ...June 27, 2007 /PRNewswire-FirstCall/ --,Alfacell C...NASE,the company,s lead drug candidate, is active...lls. , The pre-clinical in vitro and in vivo data ... 1: 107-116) through a collaboration,between Alfac...
...ORK--(BUSINESS WIRE)--Jun 27, 2007 - Gentium S.p.A...h clinical and preclinical,data that support the s...f action of Defibrotide in combination with antica...esented both an update,from the Company,s ongoing ...tory or relapsed multiple myeloma with Defibrotide...
Other Medicine Technology:In Vitro and In Vivo Data Show Alfacell's Onocanse is Active,Against Naive and Chemoresistant Neuroblastoma Cells 2In Vitro and In Vivo Data Show Alfacell's Onocanse is Active,Against Naive and Chemoresistant Neuroblastoma Cells 3Gentium's Defibrotide Seen as Active in Multiple Myeloma 2Gentium's Defibrotide Seen as Active in Multiple Myeloma 3
Zeiss offers a full range of filter sets for a variety of applications.
Dust covers for a variety of Zeiss microscopes
These objectives have more contrast than the DLL objectives for enhanced contrast with tissue culture specimens. These objectives are designed for use on inverted microscopes and therefore their mark
...that offers you much more than you have ever expec...e impressed by the outstanding quality, and functi... work as easy and safe as possible thus increasin... more time for the observation. , Contrasting...
Medicine Products: